Show simple item record

Biosimilars to treat inflammatory arthritis: the challenge of proving identity

dc.contributor.authorKay, Jonathan
dc.contributor.authorSmolen, Josef S.
dc.date2022-08-11T08:10:51.000
dc.date.accessioned2022-08-23T17:22:21Z
dc.date.available2022-08-23T17:22:21Z
dc.date.issued2013-10-01
dc.date.submitted2015-04-17
dc.identifier.citationAnn Rheum Dis. 2013 Oct;72(10):1589-93. doi: 10.1136/annrheumdis-2012-203198. Epub 2013 Jul 29. <a href="http://dx.doi.org/10.1136/annrheumdis-2012-203198">Link to article on publisher's site</a>
dc.identifier.issn0003-4967 (Linking)
dc.identifier.doi10.1136/annrheumdis-2012-203198
dc.identifier.pmid23897773
dc.identifier.urihttp://hdl.handle.net/20.500.14038/48726
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23897773&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1136/annrheumdis-2012-203198
dc.subjectAntibodies, Monoclonal
dc.subjectAntirheumatic Agents
dc.subjectArthritis, Rheumatoid
dc.subjectFemale
dc.subjectHumans
dc.subjectImmunoglobulin G
dc.subjectMale
dc.subjectMethotrexate
dc.subjectSpondylitis, Ankylosing
dc.subjectMusculoskeletal Diseases
dc.subjectRheumatology
dc.subjectSkin and Connective Tissue Diseases
dc.titleBiosimilars to treat inflammatory arthritis: the challenge of proving identity
dc.typeEditorial
dc.source.journaltitleAnnals of the rheumatic diseases
dc.source.volume72
dc.source.issue10
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/rheumatology_pubs/124
dc.identifier.contextkey7002954
dc.identifier.submissionpathrheumatology_pubs/124
dc.contributor.departmentDepartment of Medicine, Division of Rheumatology
dc.source.pages1589-93


This item appears in the following Collection(s)

Show simple item record